C. S. Pramesh Has Been Elected UICC President-Elect for the 2026–2028 Term
FDA Grants Accelerated Approval: Dostarlimab for MSI-H/dMMR Locally Advanced Rectal Cancer
A Defining Moment for Cancer Immunotherapy During ESMO 2026 - Agenus
RASolve 308: Phase III Trial Tests Zoldonrasib With Pembrolizumab and Chemotherapy in First-Line RAS G12D NSCLC
ESMO 2026: 5 Phase III Immunotherapy Trials to Watch
Revolution Medicines Begins Phase 3 RASolve 308 Trial of Zoldonrasib in RAS G12D Non-squamous NSCLC
Bari, 1943: The Disaster That Changed Cancer Treatment
Tattoos and Cancer: Is There a Link to Skin Cancer and Lymphoma?
The 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2026) is scheduled to take place in person from November 18–20, 2026, at the CCIB (Centre de Convencions Internacional de Barcelona) in Barcelona, Spain. This premier international forum, hosted by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute […]
The EANO-EORTC CNS Metastasis Meeting 2027 will take place from February 26–27, 2027, in Brussels, Belgium. Jointly held under the auspices of the European Association of Neuro-Oncology (EANO) and the European Organisation for Research and Treatment of Cancer (EORTC), the meeting is a new international forum dedicated to advancing research and care in central nervous […]
The EORTC Summit on Clinical Cancer Research 2027 will take place on March 23–24, 2027, at The SQUARE Brussels Meeting Centre in Brussels, Belgium. Organized by the European Organisation for Research and Treatment of Cancer (EORTC), the two-day Summit will bring together stakeholders across clinical cancer research to explore innovative methodologies, patient-centric approaches, quality of […]
